CD8A and triple-negative breast carcinoma: A previous study demonstrated that tumor-intrinsic Aurora-A inhibits the cytotoxicity of CD8+ T cells by promoting PD-L1 expression in a triple-negative breast cancer (TNBC) model (ref. [41]).